MarketInOut Stock Screener Log In | Sign Up
 

Takeda Pharmaceutical Co Ltd ADR

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/22/2026
Takeda Pharmaceutical Co Ltd ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization51,345 mln
Float1,578 mln
Earnings Date07/30/2026

EPS

0.38
Overpriced

P / E

42.76
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.73
Likely reliable

1-Year Forecast

20.44
Strong upside

Relative Strength

33 / 100
Underperforming

Business Description

Founded in 1781 and based in Tokyo, Takeda is one of the world's leading pharmaceutical companies, developing and selling medicines across a range of treatment areas including digestive health, cancer, rare diseases, and mental health. The company markets dozens of established drug brands globally and works alongside a broad network of research and industry partners to discover and bring new treatments to patients.

Key Fundamentals

EPS0.38
P/E42.76
ROE1.57
RPS9.33
ROIC1.99
ROA0.77
Interest Cover1.69
EBITDA, mln8,548
EV / EBITDA8.69
EV / EBIT18.98
Revenue, mln29,896
EV / Revenue2.64

Financial Strength

Altman Z-Score1.17
Piotroski F-Score 5 / 9
Beneish M-Score-2.73
Price to Intrinsic Value0.62
1-Year Target Price20.44
Shiller PE Ratio31.86
Short Ratio1.68
Short % of Float0.16

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.17% 11 / 100   
1 Month -2.4% 24 / 100   
2 Months -11.97% 14 / 100   
6 Months 15.33% 67 / 100   
1 Year 13.48% 44 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us